These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37043065)

  • 1. Glial Reaction in a Neuroinflammatory Model of Parkinson's Disease.
    Voronkov DN; Stavrovskaya AV; Potapov IA; Guschina AS; Olshanskiy AS
    Bull Exp Biol Med; 2023 Mar; 174(5):693-698. PubMed ID: 37043065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
    Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-alpha-aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson's disease in male rats.
    O'Neill E; Chiara Goisis R; Haverty R; Harkin A
    J Neurosci Res; 2019 Jul; 97(7):804-816. PubMed ID: 30924171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
    Kuter K; Olech Ł; Głowacka U
    Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's disease.
    Gómez-Gálvez Y; Fuller HR; Synowsky S; Shirran SL; Gates MA
    J Neurosci Res; 2020 Jul; 98(7):1417-1432. PubMed ID: 32270889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
    Kuter KZ; Śmiałowska M; Ossowska K
    Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss.
    Iravani MM; Sadeghian M; Rose S; Jenner P
    J Neural Transm (Vienna); 2014 Dec; 121(12):1493-505. PubMed ID: 24781752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.
    Zhang Y; Meng X; Jiao Z; Liu Y; Zhang X; Qu S
    ACS Chem Neurosci; 2020 Feb; 11(3):406-417. PubMed ID: 31909584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.
    Mirza B; Hadberg H; Thomsen P; Moos T
    Neuroscience; 2000; 95(2):425-32. PubMed ID: 10658622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
    Sharma N; Sharma S; Nehru B
    Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.
    Smajić S; Prada-Medina CA; Landoulsi Z; Ghelfi J; Delcambre S; Dietrich C; Jarazo J; Henck J; Balachandran S; Pachchek S; Morris CM; Antony P; Timmermann B; Sauer S; Pereira SL; Schwamborn JC; May P; Grünewald A; Spielmann M
    Brain; 2022 Apr; 145(3):964-978. PubMed ID: 34919646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
    Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
    Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranigral Administration of
    Luna-Herrera C; Martínez-Dávila IA; Soto-Rojas LO; Flores-Martinez YM; Fernandez-Parrilla MA; Ayala-Davila J; León-Chavez BA; Soto-Rodriguez G; Blanco-Alvarez VM; Lopez-Salas FE; Gutierrez-Castillo ME; Gatica-Garcia B; Padilla-Viveros A; Bañuelos C; Reyes-Corona D; Espadas-Alvarez AJ; Garcés-Ramírez L; Hidalgo-Alegria O; De La Cruz-López F; Martinez-Fong D
    J Immunol Res; 2020; 2020():5907591. PubMed ID: 33282962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression change of glial fibrillary acidic protein and tyrosine hydroxylase in substantia nigra of the Wistar rats exposed to chlorpyrifos: a novel environmental risk factor for Parkinson's disease.
    Sheikh A; Sheikh K
    Exp Brain Res; 2020 Sep; 238(9):2041-2051. PubMed ID: 32632573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
    Boi L; Pisanu A; Palmas MF; Fusco G; Carboni E; Casu MA; Satta V; Scherma M; Janda E; Mocci I; Mulas G; Ena A; Spiga S; Fadda P; De Simone A; Carta AR
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
    Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
    Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat.
    Iczkiewicz J; Rose S; Jenner P
    Eur J Neurosci; 2005 Apr; 21(7):1911-20. PubMed ID: 15869484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPS Triggers Acute Neuroinflammation and Parkinsonism Involving NLRP3 Inflammasome Pathway and Mitochondrial CI Dysfunction in the Rat.
    Valenzuela-Arzeta IE; Soto-Rojas LO; Flores-Martinez YM; Delgado-Minjares KM; Gatica-Garcia B; Mascotte-Cruz JU; Nava P; Aparicio-Trejo OE; Reyes-Corona D; Martínez-Dávila IA; Gutierrez-Castillo ME; Espadas-Alvarez AJ; Orozco-Barrios CE; Martinez-Fong D
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N; Nehru B
    Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.